Company Overview of ACT Biotech, Inc.
ACT Biotech, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of cancer drugs. The company develops a portfolio of oral small molecule kinase inhibitors as anti-cancer drugs. Its products include drugs with mechanisms of action in various areas, such as signal transduction and anti-angiogenesis. The company was founded in 2008 and is based in New York, New York.
369 Lexington Avenue
New York, NY 10017
Founded in 2008
Key Executives for ACT Biotech, Inc.
Similar Private Companies By Industry
|Cellular Research, Inc.||United States|
|Glycotex, Inc.||United States|
|Boston BioCom LLC||United States|
|Terpenoid Therapeutics Incorporated||United States|
|Avigen, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ACT Biotech, Inc., please visit www.actbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.